Upgrade to SI Premium - Free Trial

Form 4 RBC Bearings INC For: May 19 Filed by: Edwards Richard J

May 20, 2026 5:41 PM
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Edwards Richard J
(Last) (First) (Middle)
102 WILLENBROCK ROAD
ONE TRIBOLOGY CENTER
(Street)
OXFORD CT 06478
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RBC Bearings INC [ RBC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
V.P. and General Manager
3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/19/2026 A 132 A $ 0 11,052 (1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
NQSO 5-19-2026 grant $ 565.22 05/19/2026 A 623 05/19/2027 (2) 05/19/2033 Common Stock 623 $ 0 623 D
Option to Purchase Common Stock $ 199.16 06/03/2025 (3) 06/03/2028 Common Stock 1,000 1,000 D
Option to Purchase Common Stock $ 199.10 06/03/2025 (4) 06/03/2029 Common Stock 1,600 1,600 D
Option to Purchase Common Stock $ 199.51 06/01/2025 (5) 06/01/2030 Common Stock 1,200 1,200 D
Option to Purchase Common Stock $ 292.85 05/23/2025 (6) 05/23/2031 Common Stock 1,600 1,600 D
NQSO 5-28-2025 grant $ 364.96 05/28/2026 (7) 05/28/2032 Common Stock 1,800 1,800 D
Explanation of Responses:
1. Includes 2,932 shares of restricted stock, which vest according to the following schedule - 400 shares that vest on 6/3/2026; 800 shares 1/2 of which vest on 6/3/2026 and 1/2 vest on 6/3/2027; 600 shares 1/3 of which vest on 6/1/2026, 1/3 vest on 6/1/2027 and 1/3 vest on 6/1/2028; 600 shares 1/4 of which vest on 5/23/2026, 1/4 vest on 5/23/2027, 1/4 vest on 5/23/2028 and 1/4 vest on 5/23/2029; 400 shares 1/5 or which vest on 5/28/2026, 1/5 vest on 5/28/2027, 1/5 vest on 5/28/2028, 1/5 vest on 5/28/2029 and 1/5 vest on 5/28/2030; and 132 shares 1/5 or which vest on 5/19/2027, 1/5 vest on 5/19/2028, 1/5 vest on 5/19/2029, 1/5 vest on 5/19/2030 and 1/5 vest on 5/19/2031.
2. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/19/2027, 1/5 vest on 5/19/2028, 1/5 vest on 5/19/2029, 1/5 vest on 5/19/2030 and 1/5 vest on 5/19/2031.
3. All these options to purchase Common Stock are exerciseable except for 1,000 options that vest on 6/3/2026.
4. All these options to purchase Common Stock are exerciseable except for 1,600 options that are subject to the following vesting schedule - 1/2 vest on 6/3/2026 and 1/2 vest on 6/3/2027.
5. All these options to purchase Common Stock are exerciseable except for 1,200 options that are subject to the following vesting schedule - 1/3 vest on 6/1/2026, 1/3 vest on 6/1/2027 and 1/3 vest on 6/1/2028.
6. All these options to purchase Common Stock are exerciseable except for 1,600 options that are subject to the following vesting schedule - 1/4 vest on 5/23/2026, 1/4 vest on 5/23/2027, 1/4 vest on 5/23/2028 and 1/4 vest on 5/23/2029.
7. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/28/2026, 1/5 vest on 5/28/2027, 1/5 vest on 5/28/2028, 1/5 vest on 5/28/2029 and 1/5 vest on 5/28/2030.
/s/John J. Feeney/attorney in fact 05/20/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Categories

SEC Filings